43 results
Page 2 of 3
8-K
EX-10.1
b9ynnrx00e zqfl
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.1
ftc x54ag7nx654ymin
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
8-K
EX-10.1
mrinhjzsj d6fw
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-10.1
dbctttw3pm9sn cq4xcb
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
8-K
EX-10.1
fizybc4 era9jpmm54x
13 Apr 18
EyeGate Announces $11.25 Million Public Offering
12:00am
8-K
EX-10.1
o0xx25u983cwlx2 xg
10 Jul 15
EyeGate Signs Licensing Agreement with Valeant Pharmaceuticals for EGP-437 Combination Product in Uveitis
12:00am
10-K
18kxis
31 Mar 15
Annual report
12:00am
424B4
vwpm3dz g6
13 Feb 15
Prospectus supplement with pricing info
12:00am